What is the total return of GLUE over the past year?
Monte Rosa Therapeutics, Inc. (GLUE) delivered a return of 318.06% over the past year. Since GLUE does not currently pay dividends, the total return equals the price-only return.
Monte Rosa Therapeutics, Inc.
Monte Rosa Therapeutics, Inc. did not pay dividends during this period.
Total return equals price-only return for non-dividend stocks.
Monte Rosa Therapeutics, Inc. (GLUE) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For these stocks, total return equals price appreciation.
Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform. The calculation accounts for the compounding effect where reinvested dividends generate their own future dividends.
Monte Rosa Therapeutics, Inc. (GLUE) delivered a return of 318.06% over the past year. Since GLUE does not currently pay dividends, the total return equals the price-only return.
A $10,000 investment in Monte Rosa Therapeutics, Inc. one year ago would be worth $41,806 today, representing a gain of $31,806.
Monte Rosa Therapeutics, Inc. (GLUE) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.
Screen for dividend stocks with the highest total returns (including DRIP). See which dividend stocks actually grow your wealth.
Calculate total returns for related stocks: